EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy

Suppementary Data for manuscript: Amaral T, Pop OT, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring SS, Joerger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch CM, Forschner A, Flatz L. EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. JAAD 2023本学术手稿的补充数据： 作者：Amaral T、Pop OT、Chatziioannou E、Sinnberg T、Niessner H、Zhao J、Ring SS、Joerger M、Schroeder C、Armeanu-Ebinger S、Cozzio A、Leiter U、Thomas I、Jochum W、Garbe C、Forchhammer S、Levesque M、Mangana J、Hölzel M、Dummer R、Schürch CM、Forschner A、Flatz L 表皮生长因子受体（EGFR）表达与接受辅助基于程序性死亡受体1（PD-1）的免疫治疗的黑色素瘤队列复发相关。JAAD 2023